Literature DB >> 19885603

Different expression patterns of organic anion transporting polypeptides in osteosarcomas, bone metastases and aneurysmal bone cysts.

Richard Liedauer1, Martin Svoboda, Katrin Wlcek, Ferdi Arrich, Walter Jä, Cyril Toma, Theresia Thalhammer.   

Abstract

Organic anion transporting polypeptides (OATP) were identified as transmembrane transporters for various endo- and exogenous organic compounds (hormones, prostaglandins, anticancer drugs). OATP expression had been shown in different tissues, but not in bone tumors. Therefore, the expression pattern of all known eleven human OATPs was analyzed by quantitative RT-PCR in 21 human bone tumor specimens (osteosarcomas, bone metastases and benign aneurysmal bone cysts). Transcriptional expression of OATP1A2, 1C1, 2A1, 2B1, 3A1, 4A1, 4C1 and 5A1, but not of OATP1B1, 1B3 and 6A1 was observed in malignant and non-malignant tumor specimens at varying level. Importantly, OATP3A1, 4A1, 2B1 and 1C1 mRNA levels were significantly higher in aneurysmal bone cysts as compared to osteosarcomas. Elevated mRNA levels of OATP2A1, 1A2, and 4C1 in metastases from kidney cancer and of OATP5A1 in prostate cancer suggest that the OATP expression pattern in metastases is comparable to that of the primary tumors. Different to tissue, OATP expression in osteosarcoma cell lines HOS and MG-63, normal human osteoblast outgrowth cells (hOB) and bone marrow stromal cells (BMSC) is limited to OATP3A1 and OATP4A1. High OATP expression levels, particularly in benign bone tumors, suggest an important role of these transporters for providing hormones, their conjugates, prostaglandins and drugs in bone cells. Thereby, they may influence bone resorption and formation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19885603     DOI: 10.3892/or_00000591

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  16 in total

Review 1.  Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.

Authors:  Maria Letizia Ciavatta; Florence Lefranc; Marianna Carbone; Ernesto Mollo; Margherita Gavagnin; Tania Betancourt; Ramesh Dasari; Alexander Kornienko; Robert Kiss
Journal:  Med Res Rev       Date:  2016-12-07       Impact factor: 12.944

Review 2.  Bioactive Compounds from Marine Heterobranchs.

Authors:  Conxita Avila; Carlos Angulo-Preckler
Journal:  Mar Drugs       Date:  2020-12-21       Impact factor: 5.118

Review 3.  Interplay of drug metabolizing enzymes with cellular transporters.

Authors:  Michaela Böhmdorfer; Alexandra Maier-Salamon; Juliane Riha; Stefan Brenner; Martina Höferl; Walter Jäger
Journal:  Wien Med Wochenschr       Date:  2014-09-10

4.  Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance.

Authors:  Hannah H Lee; Brenda F Leake; Richard B Kim; Richard H Ho
Journal:  Mol Pharmacol       Date:  2016-10-24       Impact factor: 4.436

Review 5.  The expression and function of organic anion transporting polypeptides in normal tissues and in cancer.

Authors:  Amanda Obaidat; Megan Roth; Bruno Hagenbuch
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-08-15       Impact factor: 13.820

Review 6.  Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy.

Authors:  Nilay Thakkar; A Craig Lockhart; Wooin Lee
Journal:  AAPS J       Date:  2015-03-04       Impact factor: 4.009

Review 7.  Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs.

Authors:  Ioannis Sainis; Demosthenes Fokas; Katerina Vareli; Andreas G Tzakos; Valentinos Kounnis; Evangelos Briasoulis
Journal:  Mar Drugs       Date:  2010-03-15       Impact factor: 5.118

8.  Organic anion transporting polypeptides expressed in pancreatic cancer may serve as potential diagnostic markers and therapeutic targets for early stage adenocarcinomas.

Authors:  Amanda Hays; Udayan Apte; Bruno Hagenbuch
Journal:  Pharm Res       Date:  2013-01-11       Impact factor: 4.200

9.  A heptamethine cyanine dye serves as a potential marker for myeloid-derived suppressor cells.

Authors:  Young-Suk Cho; Manh-Hung Do; Hien Duong Thanh; Changjong Moon; Kwonseop Kim; Sang-Hee Cho; Hangun Kim; Hyung-Ho Ha; Chaeyong Jung
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

10.  Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy.

Authors:  Veronika Buxhofer-Ausch; Lena Secky; Katrin Wlcek; Martin Svoboda; Valentinos Kounnis; Evangelos Briasoulis; Andreas G Tzakos; Walter Jaeger; Theresia Thalhammer
Journal:  J Drug Deliv       Date:  2013-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.